Bay­er taps Roche's Bill An­der­son to lead phar­ma gi­ant as CEO

We now know where Roche’s ex-phar­ma chief Bill An­der­son is go­ing.

Ger­man phar­ma gi­ant Bay­er an­nounced Wednes­day that An­der­son will be tak­ing on the role as CEO, less than six weeks af­ter An­der­son stepped down from his perch at Roche as head of the group’s phar­ma­ceu­ti­cal di­vi­sion.

Roche an­nounced back in De­cem­ber that An­der­son would de­part on Dec. 31 to “pur­sue op­por­tu­ni­ties out­side of Roche.” His re­place­ment, Genen­tech vet and Roche’s cur­rent head of glob­al prod­uct strat­e­gy, Tere­sa Gra­ham, will start her role in March.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER